- Home
- NLSP vs AIFU Comparison
NLSP vs AIFU Comparison
Compare NLSP & AIFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NLSP
- AIFU
- Stock Information
- Founded
- NLSP 2015
- AIFU 1998
- Country
- NLSP Switzerland
- AIFU China
- Employees
- NLSP N/A
- AIFU N/A
- Industry
- NLSP Biotechnology: Pharmaceutical Preparations
- AIFU
- Sector
- NLSP Health Care
- AIFU
- Exchange
- NLSP Nasdaq
- AIFU NYSE
- Market Cap
- NLSP 5.8M
- AIFU 6.5M
- IPO Year
- NLSP 2021
- AIFU 2007
- Fundamental
- Price
- NLSP $2.30
- AIFU $3.11
- Analyst Decision
- NLSP
- AIFU
- Analyst Count
- NLSP 0
- AIFU 0
- Target Price
- NLSP N/A
- AIFU N/A
- AVG Volume (30 Days)
- NLSP 423.9K
- AIFU 156.2K
- Earning Date
- NLSP 06-17-2025
- AIFU 06-17-2025
- Dividend Yield
- NLSP N/A
- AIFU N/A
- EPS Growth
- NLSP N/A
- AIFU 61.54
- EPS
- NLSP N/A
- AIFU 23.02
- Revenue
- NLSP N/A
- AIFU $247,815,758.00
- Revenue This Year
- NLSP N/A
- AIFU N/A
- Revenue Next Year
- NLSP N/A
- AIFU N/A
- P/E Ratio
- NLSP N/A
- AIFU $0.14
- Revenue Growth
- NLSP N/A
- AIFU N/A
- 52 Week Low
- NLSP $1.30
- AIFU $1.50
- 52 Week High
- NLSP $18.39
- AIFU $3.97
- Technical
- Relative Strength Index (RSI)
- NLSP 65.15
- AIFU N/A
- Support Level
- NLSP $1.58
- AIFU N/A
- Resistance Level
- NLSP $2.39
- AIFU N/A
- Average True Range (ATR)
- NLSP 0.23
- AIFU 0.00
- MACD
- NLSP 0.02
- AIFU 0.00
- Stochastic Oscillator
- NLSP 89.29
- AIFU 0.00
About NLSP NLS Pharmaceutics Ltd.
NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.
About AIFU FANHUA INC SPON ADS EACH REPR 20 ORD SHS
AIFU Inc is an independent financial services provider in China. It offer end-to-end business solutions spanning compliance, technology, products, services, capital flow and professional training. It connects customers with insurance protection, retirement planning, health management, asset management, and family governance services. The company operated in two segments: the insurance agency segment, which derives maximum revenue, consists of providing agency services for distributing life insurance products and non-life insurance products on behalf of insurance companies, and the claims adjusting segment consisting of providing pre-underwriting survey services, claims adjusting services, disposal of residual value services, loading/unloading supervision services and consulting services.